ENG rs1064794220: Understanding Hereditary Hemorrhagic Telangiectasia

What each genotype means

What is the rs1064794220 Variant?

The rs1064794220 variant is a specific change in the DNA sequence of the ENG gene. In genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is located within the coding region of the ENG gene, which is situated on chromosome 9. Because it occurs in a gene responsible for critical vascular functions, researchers monitor such variants to understand how they might alter the structure or expression of the resulting protein. While many variants in the human genome are benign, those occurring in genes like ENG are often studied for their potential to disrupt normal biological processes. This variant is categorized as a trait-associated marker, meaning it has been identified in studies investigating the genetic basis of specific health conditions.

The Role of the ENG Gene

The ENG gene encodes a protein called endoglin, which is primarily found on the surface of endothelial cells—the cells that line the interior of blood vessels. Endoglin plays a vital role in the transforming growth factor-beta (TGF-beta) signaling pathway, which is essential for the development and maintenance of the vascular system. By helping regulate how blood vessels form and stabilize, endoglin ensures that the circulatory system functions correctly. When the ENG gene is mutated, it can lead to a condition known as hereditary hemorrhagic telangiectasia (HHT), or Osler-Weber-Rendu syndrome. In this condition, the lack of functional endoglin protein impairs the formation of capillaries, leading to the development of arteriovenous malformations. These are direct connections between arteries and veins that bypass the capillary network, which can cause bleeding and other vascular complications.

Research and Clinical Significance

Research into the ENG gene has identified hundreds of variants that contribute to HHT. The evidence linking specific variants in ENG to HHT is generally considered strong, as the gene is a primary driver of the condition. The rs1064794220 variant is specifically noted in clinical databases for its association with HHT, a multisystemic vascular dysplasia. Scientific studies often use genetic testing to identify these variants in individuals presenting with symptoms such as recurrent nosebleeds, telangiectasias (small dilated blood vessels), or internal arteriovenous malformations. It is important to note that the strength of evidence for any single variant can vary based on the number of documented cases and functional studies performed. Because HHT is an autosomal dominant condition, even a single copy of a pathogenic variant can be sufficient to influence the development of the disease, though clinical expression can vary significantly between individuals.

Population Frequency and Interpretation

The rs1064794220 variant is classified as rare in the general population. Rare variants are typically found at very low frequencies across different ancestral groups, which distinguishes them from common polymorphisms that might be shared by a large percentage of the population. Because this variant is rare, it is not commonly encountered in standard population-wide genetic screening. When a rare variant is identified in a clinical setting, it is often interpreted in the context of a patient's specific symptoms and family history. Genetic counselors and medical professionals use this information to help families understand the inheritance patterns of HHT. If you have received information about this variant from a genetic test, it is essential to discuss the findings with a qualified healthcare provider or a genetic counselor who can provide context based on your personal health history and clinical presentation.

Managing Genetic Information

Information regarding genetic variants like rs1064794220 should be used for educational purposes and to facilitate informed discussions with medical professionals. It is important to understand that the presence of a variant does not automatically equate to a clinical diagnosis. Genetic testing results are complex and should always be interpreted by a clinician who can integrate them with physical examinations and other diagnostic tests. You cannot use this information to self-diagnose or make medical decisions. If you are concerned about HHT or other vascular conditions, consult a specialist, such as a vascular medicine physician or a geneticist. They can provide appropriate screening, monitoring, and management strategies tailored to your needs. Always rely on professional medical advice rather than online databases when making decisions about your health or the health of your family members.

Frequently asked questions

Sources & further reading

Related variants in ENG